以用户需求为中心，老百姓大药房加速推动商采革新

Core Insights - The pharmaceutical retail industry is experiencing accelerated consolidation, with companies focusing on strengthening core competitiveness and building brand moats to navigate the evolving landscape [1] Group 1: Business Strategy - The company aims to enhance product strength and supply chain efficiency by 2025, focusing on a user-demand-driven model and deep reform of its procurement system [1] - The company has integrated procurement functions to break down departmental barriers, significantly improving supply chain responsiveness and cost control [2] - A new category management system has been established, shifting from traditional drug classifications to a user-demand-based classification, optimizing product selection to meet consumer pain points [2] Group 2: Brand Development - The company is accelerating its private label strategy by focusing on high-quality, cost-effective products and enhancing consumer experience [3] - The "老百姓优选" brand emphasizes safety, health, and cost-effectiveness, expanding its product matrix to include health foods and daily necessities [3] Group 3: Logistics and Technology - The company has developed an efficient logistics network with a national logistics hub and multiple regional distribution centers, covering over 320,000 square meters of warehouse space [3] - Advanced systems such as SRM, ERP, WMS, and TMS have been implemented for digital and visual management of the supply chain, enhancing operational efficiency [3] Group 4: Future Outlook - The company is well-positioned to lead the industry by leveraging its comprehensive supply chain, diverse product offerings, and quality health services in response to the upgrading health consumption demand [4]